Kathryn Clarke

Statistics

Publications

Citations

701

H-Index

Active since

1999

Affiliations

Dana-Farber Brigham Cancer Center(Current)

Dana-Farber Cancer Institute

Kathryn Clarke is an author at Dana-Farber Brigham Cancer Center specializing in chemotherapy, metastatic breast cancer treatment, and metastatic breast cancer.

Publications per year

1999–2006

Publications

Clinical Activity of Trastuzumab and Vinorelbine in Women With HER2-Overexpressing Metastatic Breast Cancer

Harold J. Burstein, Irene Kuter, Susana M. Campos et al. · Journal of Clinical Oncology · 2001 · 369 citations

Medicine, Oncology, Pharmacology +17

Docetaxel Administered on a Weekly Basis for Metastatic Breast Cancer

Harold J. Burstein, Judith Manola, Jerry Younger et al. · Journal of Clinical Oncology · 2000 · 261 citations

Medicine, Oncology, Pharmacotherapy +16

Phase I study of Doxil and vinorelbine in metastatic breast cancer

Harold J. Burstein, Michael J. Ramirez, William P. Petros et al. · Annals of Oncology · 1999 · 46 citations · Full text

Medicine, Oncology, Pharmacology +12

Rebeccamycin analog for refractory breast cancer: A randomized phase II trial of dosing schedules

Harold J. Burstein, Beth Overmoyer, Rebecca Gelman et al. · Investigational New Drugs · 2006 · 25 citations

Medicine, Oncology, Pharmacology +10

1–4 of 4